04:29 PM EST, 11/20/2025 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on November 18, 2025, sold 20,000 shares in Revolution Medicines ( RVMD ) for $1,407,586. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 958,761 common shares of the company, with 247,863 shares held directly and 710,898 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071725000384/xslF345X05/form4.xml